The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Annual Report 2018
The EDCTP 2018 Annual Report has been published in a new digital format.
Introductions by Dr Mark Palmer, Dr Michael Makanga, portfolio infographics and project highlights. As PDF downloads: Financial Statements 2018 and Summary Annual Report 2018
EDCTP 2003-2018
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. EDCTP succeeds in bringing together researchers and institutions in Europe and Africa.
EDCTP Fellows
The EDCTP Alumni Network has a digital platform to connect and facilitate the collaboration of former and current EDCTP fellows. The Alumni Network was launched in 2017 and the platform in 2018.
Latest news
Annual Report 2018 – a strong portfolio halfway EDCTP2
EDCTP published its Annual Report 2018 – 15th anniversary of the EDCTP programme in a new digital format. The report gives a quick overview of the milestones in the development of the partnership since 2003 and presents the strong EDCTP2…
EDCTP invests €18 million in evaluation of candidate malaria vaccine portfolio
EDCTP awarded a grant of EUR 18 million to an international consortium to evaluate a portfolio of three innovative candidate malaria vaccines that aim to block transmission of the Plasmodium falciparum parasite. The PfTBV consortium is coordinated by Dr Issaka…